Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care".
Letter to the Editor: "Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care".
J Clin Endocrinol Metab. 2020 Mar 01;105(3):
Authors: de Carvalho LSF, Coelho OR, Sposito AC
PMID: 32036386 [PubMed - in process]
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: de Carvalho LSF, Coelho OR, Sposito AC Tags: J Clin Endocrinol Metab Source Type: research